• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase.重组人源卡氏肺孢子虫二氢叶酸还原酶的表达与鉴定
Antimicrob Agents Chemother. 2000 Nov;44(11):3092-6. doi: 10.1128/AAC.44.11.3092-3096.2000.
2
Purification and properties of recombinant Pneumocystis carinii dihydrofolate reductase.重组卡氏肺孢子虫二氢叶酸还原酶的纯化及性质
Protein Expr Purif. 1991 Oct-Dec;2(5-6):313-6. doi: 10.1016/1046-5928(91)90088-z.
3
Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.重组卡氏肺孢子虫二氢叶酸还原酶的复性及该酶的特性研究
Protein Expr Purif. 1993 Feb;4(1):16-23. doi: 10.1006/prep.1993.1003.
4
Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii.在卡氏肺孢子虫生长的培养模型中对二氢叶酸还原酶强效抑制剂的评估。
Antimicrob Agents Chemother. 1995 Nov;39(11):2436-41. doi: 10.1128/AAC.39.11.2436.
5
Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates.来自致病性真菌卡氏肺孢子虫的二氢叶酸还原酶:催化特性及与抗叶酸药物的相互作用。
Arch Biochem Biophys. 1993 Sep;305(2):499-508. doi: 10.1006/abbi.1993.1453.
6
Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.2,4-二氨基-5-[2-甲氧基-5-(ω-羧基烷氧基)苄基]嘧啶对卡氏肺孢子虫、刚地弓形虫和鸟分枝杆菌二氢叶酸还原酶的抑制作用:相对于甲氧苄啶,其效力显著提高,相对于乙胺嘧啶,具有种属选择性。
J Med Chem. 2002 Jan 3;45(1):233-41. doi: 10.1021/jm010407u.
7
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.亲脂性抗叶酸剂作为抗机会性感染的药物。1. 在体外评估中对弓形虫和卡氏肺孢子虫优于三甲曲沙和吡利曲辛的药物。
J Med Chem. 1996 Mar 15;39(6):1271-80. doi: 10.1021/jm950760y.
8
2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.甲氧苄啶的2,4-二氨基-6,7-二氢-5H-环戊并[d]嘧啶类似物作为卡氏肺孢子虫和刚地弓形虫二氢叶酸还原酶的抑制剂
J Med Chem. 1998 Mar 12;41(6):913-8. doi: 10.1021/jm970614n.
9
Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.开发一种用于快速筛选人源卡氏肺孢子虫二氢叶酸还原酶抑制剂的酵母检测方法。
Antimicrob Agents Chemother. 2002 Sep;46(9):3101-3. doi: 10.1128/AAC.46.9.3101-3103.2002.
10
Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent.抗叶酸剂对卡氏肺孢子虫二氢叶酸还原酶的活性及一种强效新制剂的鉴定。
J Exp Med. 1987 Mar 1;165(3):926-31. doi: 10.1084/jem.165.3.926.

引用本文的文献

1
Characterization of the Three DHFRs and K65P Variant: Enhanced Substrate Affinity and Molecular Dynamics Analysis.三种 DHFR 及 K65P 变异体的特征:增强的底物亲和力和分子动力学分析。
Protein J. 2024 Oct;43(5):935-948. doi: 10.1007/s10930-024-10228-7. Epub 2024 Aug 23.
2
A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.肺炎支原体生物学与流行病学的分子窗口
Clin Microbiol Rev. 2018 Jun 13;31(3). doi: 10.1128/CMR.00009-18. Print 2018 Jul.
3
Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.新型吡啶并[2,3-d]嘧啶类似物的设计、合成与分子建模作为抗叶酸剂;杂环的 Buchwald-Hartwig 胺化反应的应用。
J Med Chem. 2013 Jun 13;56(11):4422-41. doi: 10.1021/jm400086g. Epub 2013 May 21.
4
Kinetic and structural analysis for potent antifolate inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and human dihydrofolate reductases and their active-site variants.对肺孢子菌、卡氏肺孢子虫和人二氢叶酸还原酶及其活性位点变异体的强效抗叶酸抑制的动力学和结构分析。
Antimicrob Agents Chemother. 2013 Jun;57(6):2669-77. doi: 10.1128/AAC.00172-13. Epub 2013 Apr 1.
5
Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.肺炎支原体和人二氢叶酸还原酶抑制剂动力学的相关性与人类活性位点突变酶复合物的结构数据。
Biochemistry. 2009 Mar 3;48(8):1702-11. doi: 10.1021/bi801960h.
6
Towards new antifolates targeting eukaryotic opportunistic infections.靶向真核生物机会性感染的新型抗叶酸剂研究进展
Eukaryot Cell. 2009 Apr;8(4):483-6. doi: 10.1128/EC.00298-08. Epub 2009 Jan 23.
7
Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.与预防失败相关的耶氏肺孢子菌二氢叶酸还原酶突变
Antimicrob Agents Chemother. 2004 Nov;48(11):4301-5. doi: 10.1128/AAC.48.11.4301-4305.2004.
8
A new name (Pneumocystis jiroveci) for Pneumocystis from humans.人类肺孢子菌的新名称(耶氏肺孢子菌)
Emerg Infect Dis. 2002 Sep;8(9):891-6. doi: 10.3201/eid0809.020096.
9
Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.开发一种用于快速筛选人源卡氏肺孢子虫二氢叶酸还原酶抑制剂的酵母检测方法。
Antimicrob Agents Chemother. 2002 Sep;46(9):3101-3. doi: 10.1128/AAC.46.9.3101-3103.2002.

本文引用的文献

1
Studies on plant amylases: The effect of starch concentration upon the velocity of hydrolysis by the amylase of germinated barley.植物淀粉酶的研究:淀粉浓度对发芽大麦淀粉酶水解速度的影响。
Biochem J. 1932;26(5):1406-21. doi: 10.1042/bj0261406.
2
Recombinant carboxyltransferase responsive to redox of pea plastidic acetyl-CoA carboxylase.对豌豆质体乙酰辅酶A羧化酶氧化还原反应有响应的重组羧基转移酶
J Biol Chem. 2000 Apr 7;275(14):10702-8. doi: 10.1074/jbc.275.14.10702.
3
Molecular characterisation of Trypanosoma brucei alkyl dihydroxyacetone-phosphate synthase.布氏锥虫烷基二羟基丙酮磷酸合酶的分子特征分析
Mol Biochem Parasitol. 1999 Oct 25;104(1):55-66. doi: 10.1016/s0166-6851(99)00141-3.
4
Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.卡氏肺孢子虫二氢蝶酸合酶而非二氢叶酸还原酶基因突变与先前使用甲氧苄啶-磺胺甲恶唑或氨苯砜有关。
J Infect Dis. 1999 Dec;180(6):1969-78. doi: 10.1086/315148.
5
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.卡氏肺孢子虫二氢蝶酸合酶基因突变对艾滋病相关卡氏肺孢子虫肺炎结局的影响。
Lancet. 1999 Oct 16;354(9187):1347-51. doi: 10.1016/S0140-6736(99)03320-6.
6
Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.与艾滋病患者中磺胺类和砜类药物预防失败相关的卡氏肺孢子虫突变。
AIDS. 1998 May 28;12(8):873-8. doi: 10.1097/00002030-199808000-00009.
7
Eukaryotic dihydrofolate reductase.真核生物二氢叶酸还原酶
Adv Enzymol Relat Areas Mol Biol. 1995;70:23-102. doi: 10.1002/9780470123164.ch2.
8
Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.重组卡氏肺孢子虫二氢叶酸还原酶的复性及该酶的特性研究
Protein Expr Purif. 1993 Feb;4(1):16-23. doi: 10.1006/prep.1993.1003.
9
Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates.来自致病性真菌卡氏肺孢子虫的二氢叶酸还原酶:催化特性及与抗叶酸药物的相互作用。
Arch Biochem Biophys. 1993 Sep;305(2):499-508. doi: 10.1006/abbi.1993.1453.
10
Dihydrofolate reductase hysteresis and its effect of inhibitor binding analyses.二氢叶酸还原酶滞后现象及其抑制剂结合分析的作用
Biochemistry. 1981 Mar 31;20(7):1710-6. doi: 10.1021/bi00510a002.

重组人源卡氏肺孢子虫二氢叶酸还原酶的表达与鉴定

Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase.

作者信息

Ma L, Kovacs J A

机构信息

Critical Care Medicine Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Antimicrob Agents Chemother. 2000 Nov;44(11):3092-6. doi: 10.1128/AAC.44.11.3092-3096.2000.

DOI:10.1128/AAC.44.11.3092-3096.2000
PMID:11036028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC101608/
Abstract

Dihydrofolate reductase (DHFR) is the target of trimethoprim (TMP), which has been widely used in combination with sulfa drugs for treatment and prophylaxis of Pneumocystis carinii pneumonia. While the rat-derived P. carinii DHFR has been well characterized, kinetic studies of human-derived P. carinii DHFR, which differs from rat-derived P. carinii DHFR by 38% in amino acid sequence, have not been reported to date. Here we report on the expression and kinetic characterization of the recombinant human-derived P. carinii DHFR. The 618-bp coding sequence of the human-derived P. carinii DHFR gene was expressed in Escherichia coli. As determined by sodium dodecyl sulfate-polyacrylamide gel eletrophoresis, the purified enzyme had a molecular mass of 25 kDa, consistent with that predicted from the DNA sequence. Kinetic analysis showed that the K(m) values for dihydrofolate and NADPH were 2.7 +/- 0.3 and 14.0 +/- 4.3 microM, respectively, which are similar to those reported for rat-derived P. carinii DHFR. Inhibition studies revealed that both TMP and pyrimethamine were poor inhibitors of human-derived P. carinii DHFR, with K(i) values of 0.28 +/- 0.08 and 0.065 +/- 0.005 microM, respectively, while trimetrexate and methotrexate were potent inhibitors, with K(i) values of 0.23 +/- 0.03 and 0.016 +/- 0.004 nM, respectively. The availability of purified recombinant enzyme in large quantities should facilitate the identification of antifolate inhibitors with greater potency and higher selectivity for human-derived P. carinii DHFR.

摘要

二氢叶酸还原酶(DHFR)是甲氧苄啶(TMP)的作用靶点,TMP已广泛与磺胺类药物联合用于治疗和预防卡氏肺孢子虫肺炎。虽然大鼠源卡氏肺孢子虫DHFR已得到充分表征,但人源卡氏肺孢子虫DHFR的动力学研究迄今尚未见报道,其人源卡氏肺孢子虫DHFR与大鼠源卡氏肺孢子虫DHFR的氨基酸序列差异为38%。在此,我们报道重组人源卡氏肺孢子虫DHFR的表达及动力学特征。人源卡氏肺孢子虫DHFR基因的618 bp编码序列在大肠杆菌中表达。经十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定,纯化后的酶分子量为25 kDa,与DNA序列预测的结果一致。动力学分析表明,二氢叶酸和NADPH的K(m)值分别为2.7±0.3和14.0±4.3 μM,这与大鼠源卡氏肺孢子虫DHFR报道的值相似。抑制研究表明,TMP和乙胺嘧啶对人源卡氏肺孢子虫DHFR的抑制作用较弱,K(i)值分别为0.28±0.08和0.065±0.005 μM,而三甲曲沙和甲氨蝶呤是强效抑制剂,K(i)值分别为0.23±0.03和0.016±0.004 nM。大量纯化重组酶的可得性应有助于鉴定对人源卡氏肺孢子虫DHFR具有更高效力和更高选择性的抗叶酸抑制剂。